Beyond the Bottleneck: AI-Driven Patient Recruitment for a New Era

Session details:

Patient recruitment remains the single greatest threat to clinical trial timelines — responsible for the majority of delays, budget overruns, and site failures that plague drug development year after year. For decades, the industry has responded by doing more of the same: broader site networks, bigger advertising budgets, and traditional outreach models that were never built for the way patients seek help today.

We are now in a fundamentally different era. Patients are actively searching for solutions to their health challenges online — in real time, with intent, and at scale. AI technology can now find these motivated individuals precisely when they are looking, matching them to trials they may never have discovered through conventional channels within a matter of minutes not months.

TrialWire exists at this intersection. Drawing on data from recent industry coverage highlighting unprecedented demand for smarter recruitment approaches, this session will explore why the old models are structurally broken, why Biotechs that build AI-enabled recruitment into development now will secure faster more predictable timelines and budget and what AI-driven intent-based recruitment looks like in practice.

This is not incremental improvement. This is a new paradigm — and the companies embracing it from day zero are owning their timelines and predictability of enrolment, costs that investors expect.